A DDI Study of FDL169 and FDL176 in Healthy Subjects
Status:
Suspended
Trial end date:
2020-02-01
Target enrollment:
Participant gender:
Summary
A DDI study to assess the safety, tolerability and pharmacokinetics of both; doses of FDL176
with and without co-administration of FDL169 and doses of FDL169 with and without
co-administration of FDL176.